COPD: open trials in New Zealand

7 open trials have a site in New Zealand. Registry data; only the trial team decides who can take part.

NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Trial Treatment · Phase 3 · AstraZeneca
Research Site, Auckland · Research Site, Hamilton West · Research Site, Tauranga
Registry updated 2026-10-09
NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Auckland · GSK Investigational Site, Christchurch · GSK Investigational Site, Ebdentown · GSK Investigational Site, Hamilton · GSK Investigational Site, Rotorua · GSK Investigational Site, Takapuna
Registry updated 2026-10-05
NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Ebdentown · GSK Investigational Site, Rotorua
Registry updated 2026-07-28
NCT06944925
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Trial Treatment · Phase 1 · Bambusa Therapeutics
Momentum Clinical Research, Pukekohe · Momentum Clinical Research Hamilton, Rotorua · Momentum Clinical Research, Wellington
Registry updated 2026-07-01
NCT02796937
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Trial Treatment · Phase 3 · Grifols Therapeutics LLC
Grifols Investigative Site, Auckland · Grifols Investigative Site, Christchurch · Grifols Investigative Site, Hamilton
Registry updated 2026-06-23
NCT06972589
The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.
Trial Treatment · Fisher and Paykel Healthcare
Fisher and Paykel Healthcare Sleep Laboratory, Auckland
Registry updated 2025-05-15
NCT06682286
Assessment of Breathing Pattern During NIV
Trial Treatment · Fisher and Paykel Healthcare
Fisher and Paykel Healthcare Sleep Laboratory, Auckland
Registry updated 2025-05-11

All COPD trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

COPD: open trials in New Zealand

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.

Assessment of Breathing Pattern During NIV